GPR37 and Parkinson disease: Furthermore, treatment with GM1, a brain-expressed ganglioside, significantly improved the survival of cells stably expressing GPR37 compared to WT cells lacking GPR37 in an MPP + -induced N2a PD cell model (Hertz et al., 2021).